Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis
{{output}}
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare and fatal adverse reaction to pembrolizumab. The clinical characteristics of pembrolizumab induced HLH are unknown. Exploring the clinical features of pembrolizumab i... ...
